ATE498020T1 - 5t4 rna in plasma und serum als marker für neoplastische erkrankungen - Google Patents

5t4 rna in plasma und serum als marker für neoplastische erkrankungen

Info

Publication number
ATE498020T1
ATE498020T1 AT01964280T AT01964280T ATE498020T1 AT E498020 T1 ATE498020 T1 AT E498020T1 AT 01964280 T AT01964280 T AT 01964280T AT 01964280 T AT01964280 T AT 01964280T AT E498020 T1 ATE498020 T1 AT E498020T1
Authority
AT
Austria
Prior art keywords
rna
serum
plasma
marker
neoplastic diseases
Prior art date
Application number
AT01964280T
Other languages
English (en)
Inventor
Michael Kopreski
Christopher Gocke
Original Assignee
Oncomedx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/649,371 external-priority patent/US6794135B1/en
Application filed by Oncomedx Inc filed Critical Oncomedx Inc
Application granted granted Critical
Publication of ATE498020T1 publication Critical patent/ATE498020T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01964280T 2000-08-28 2001-08-21 5t4 rna in plasma und serum als marker für neoplastische erkrankungen ATE498020T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/649,371 US6794135B1 (en) 1996-03-26 2000-08-28 Method for detection of 5T4 RNA in plasma or serum
PCT/US2001/026119 WO2002018645A2 (en) 2000-08-28 2001-08-21 5t4 rna in plasma and serum as a marker for neoplastic disease

Publications (1)

Publication Number Publication Date
ATE498020T1 true ATE498020T1 (de) 2011-02-15

Family

ID=24604503

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01964280T ATE498020T1 (de) 2000-08-28 2001-08-21 5t4 rna in plasma und serum als marker für neoplastische erkrankungen

Country Status (6)

Country Link
US (2) US20050260594A1 (de)
EP (1) EP1354060B1 (de)
AT (1) ATE498020T1 (de)
AU (1) AU2001285157A1 (de)
DE (1) DE60144027D1 (de)
WO (1) WO2002018645A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003272367A1 (en) * 2002-09-12 2004-04-30 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method for detection of micro-metastasis
US8252529B2 (en) * 2008-06-12 2012-08-28 The Invention Science Fund I, Llc Methods for collecting and detecting oligonucleotides
US8614057B2 (en) * 2008-06-12 2013-12-24 The Invention Science Fund I, Llc Methods for collecting and detecting oligonucleotides
US8252528B2 (en) * 2008-06-12 2012-08-28 The Invention Science Fund I, Llc Methods, compositions, and kits for collecting and detecting oligonucleotides
GB0822836D0 (en) * 2008-12-15 2009-01-21 Oxford Biomedica Ltd Method

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869053A (en) * 1988-03-04 1999-02-09 Cancer Research Campaign Technology, Ltd. 5T4 antigen from human trophoblasts
WO1989007947A1 (en) * 1988-03-04 1989-09-08 Cancer Research Campaign Technology Limited Improvements relating to antigens
AU675774B2 (en) * 1991-10-04 1997-02-20 Children's Hospital Of Philadelphia, The Detecting digeorge syndrome mutations
PT938320E (pt) * 1996-03-26 2010-09-22 Michael S Kopreski Método que permite a utilização de arn extracelular extraído de plasma ou de soro para detectar, monitorizar ou avaliar o cancro
US5939262A (en) * 1996-07-03 1999-08-17 Ambion, Inc. Ribonuclease resistant RNA preparation and utilization
GB9704444D0 (en) * 1997-03-04 1997-04-23 Isis Innovation Non-invasive prenatal diagnosis
US6664056B2 (en) * 2000-10-17 2003-12-16 The Chinese University Of Hong Kong Non-invasive prenatal monitoring
FR2839015A1 (fr) * 2002-04-29 2003-10-31 Conception & Dev Michelin Sa Bandage flexible non pneumatique
CA2513292C (en) * 2003-01-17 2016-04-05 The Chinese University Of Hong Kong Circulating mrna as diagnostic markers for pregnancy-related disorders

Also Published As

Publication number Publication date
EP1354060A2 (de) 2003-10-22
AU2001285157A1 (en) 2002-03-13
EP1354060B1 (de) 2011-02-09
US20080200410A1 (en) 2008-08-21
US20050260594A1 (en) 2005-11-24
WO2002018645A3 (en) 2003-07-24
WO2002018645A2 (en) 2002-03-07
DE60144027D1 (de) 2011-03-24

Similar Documents

Publication Publication Date Title
AU2002327308A1 (en) Methods for evaluating pathologic conditions using extracellular rna
WO2002054081A3 (en) Proteins, genes and their use for diagnosis and treatment of kidney response
CA2421007A1 (en) Method for detection of htr and htert telomerase-associated rna in plasma or serum
DE69933989D1 (de) Biomarker und targets für die diagnose, prognose und behandlung von prostat krankheiten
ATE419516T1 (de) Monoklonale antikörper und zelloberflächenantigene zum nachweis und zur behandlung von kleinzelligem lungenkrebs (sclc)
ATE518477T1 (de) Fluoreszenzvermittelte molekulartomographie
EP1578923A4 (de) Lösliche mic-polypeptide als marker zur diagnose, prognose und behandlung von krebs sowie autoimmunkrankheiten oder -erkrankungen
WO2002059604A8 (en) Diagnosis and treatment of multiple sclerosis
WO2003028531A3 (en) Detection of tumor rna in plasma and serum
EP1913391A4 (de) Quantitative assays für pdgfr- in körperflüssigkeiten
WO2006063093A3 (en) Methods for diagnosis and treatment of crohn's disease
DE50103907D1 (de) Verwendungen der Aldose-1-Epimerase (Mutarotase) für die Diagnose von Entzündungserkrankungen und Sepsis
WO2003001183A3 (en) Methods for detecting and monitoring cox-2 rna in plasma and serum
DE602006015966D1 (de) Verfahren zur vorhersage und überwachung einer unmittelbaren reaktion auf eine krebstherapie
IL151448A0 (en) Proteins
ATE498020T1 (de) 5t4 rna in plasma und serum als marker für neoplastische erkrankungen
EP1451552A4 (de) Zum nachweisen von erkrankungen der brust geeignete reagenzien und verfahren
WO2003048734A3 (en) Detection of matrix metalloproteinase rna in plasma and serum
BRPI0315735A8 (pt) método para o ensaio de ngf a diagnose in vitro de câncer de mama e uso terapêutico
WO2001062785A3 (en) Protein and gene and their use for diagnosis and treatment of schizophrenia
WO2001069261A3 (en) Proteins, genes and their use for diagnosis and treatment of vascular dementia
DE602004029477D1 (de) Methode zur detektion und beobachtung von krankheiten durch analyse von an den zellen gebundenen nukleinsäuren
ATE335806T1 (de) Diagnosisverfahren für whipples krankheit
ATE420210T1 (de) Diagnose des brustkrebsrisikos
WO2002054080A3 (en) Proteins, genes and their use for diagnosis and treatment of vascular response

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties